BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 24840899)

  • 1. Increased circulating microRNA-155 as a potential biomarker for breast cancer screening: a meta-analysis.
    Wang F; Hou J; Jin W; Li J; Yue Y; Jin H; Wang X
    Molecules; 2014 May; 19(5):6282-93. PubMed ID: 24840899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A meta-analysis of microRNA-17 as a potential biomarker in diagnosis of colorectal cancer.
    Liu T; Yin L; Yan G; Li C; Wang L
    Cell Mol Biol (Noisy-le-grand); 2018 May; 64(6):86-93. PubMed ID: 29808806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum microRNA-21 as a potential diagnostic biomarker for breast cancer: a systematic review and meta-analysis.
    Li S; Yang X; Yang J; Zhen J; Zhang D
    Clin Exp Med; 2016 Feb; 16(1):29-35. PubMed ID: 25516467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The accuracy of circulating microRNA-21 in the diagnosis of colorectal cancer: a systematic review and meta-analysis.
    Xu F; Xu L; Wang M; An G; Feng G
    Colorectal Dis; 2015 May; 17(5):O100-7. PubMed ID: 25683351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery and function exploration of microRNA-155 as a molecular biomarker for early detection of breast cancer.
    Liu X; Chang Q; Wang H; Qian H; Jiang Y
    Breast Cancer; 2021 Jul; 28(4):806-821. PubMed ID: 33475963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum microRNA-21 as a diagnostic marker for lung carcinoma: a systematic review and meta-analysis.
    Yang X; Guo Y; Du Y; Yang J; Li S; Liu S; Li K; Zhang D
    PLoS One; 2014; 9(5):e97460. PubMed ID: 24865991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential role of microRNA-21 in the diagnosis of gastric cancer: a meta-analysis.
    Zeng Z; Wang J; Zhao L; Hu P; Zhang H; Tang X; He D; Tang S; Zeng Z
    PLoS One; 2013; 8(9):e73278. PubMed ID: 24023850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood-Based Circulating MicroRNAs are Potential Diagnostic Biomarkers for Leukemia: Result from a Meta-Analysis.
    Xu LH; Guo Y; Zhang XL; Chen JJ; Hu SY
    Cell Physiol Biochem; 2016; 38(3):939-49. PubMed ID: 26938054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential role of microRNA-126 in the diagnosis of cancers: A systematic review and meta-analysis.
    Yan J; Ma S; Zhang Y; Yin C; Zhou X; Zhang G
    Medicine (Baltimore); 2016 Aug; 95(35):e4644. PubMed ID: 27583885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A panel of circulating miRNAs as diagnostic biomarkers for screening multiple myeloma: a systematic review and meta-analysis.
    Zhang L; Cao D; Tang L; Sun C; Hu Y
    Int J Lab Hematol; 2016 Dec; 38(6):589-599. PubMed ID: 27870469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating miR-128 as a potential diagnostic biomarker for glioma.
    Liang RF; Li M; Yang Y; Wang X; Mao Q; Liu YH
    Clin Neurol Neurosurg; 2017 Sep; 160():88-91. PubMed ID: 28704779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The diagnostic role of microRNA-34a in breast cancer: a systematic review and meta-analysis.
    Imani S; Zhang X; Hosseinifard H; Fu S; Fu J
    Oncotarget; 2017 Apr; 8(14):23177-23187. PubMed ID: 28423566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic value of circulating microRNAs as biomarkers for breast cancer: a meta-analysis study.
    Cui Z; Lin D; Song W; Chen M; Li D
    Tumour Biol; 2015 Feb; 36(2):829-39. PubMed ID: 25296735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Panels of circulating microRNAs as potential diagnostic biomarkers for breast cancer: a systematic review and meta-analysis.
    Nguyen THN; Nguyen TTN; Nguyen TTM; Nguyen LHM; Huynh LH; Phan HN; Nguyen HT
    Breast Cancer Res Treat; 2022 Nov; 196(1):1-15. PubMed ID: 36085533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic significance of circulating miRNAs in systemic lupus erythematosus.
    Zheng X; Zhang Y; Yue P; Liu L; Wang C; Zhou K; Hua Y; Wu G; Li Y
    PLoS One; 2019; 14(6):e0217523. PubMed ID: 31163082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of circulating microRNA biomarkers for breast cancer detection: a meta-analysis.
    Liu L; Wang S; Cao X; Liu J
    Tumour Biol; 2014 Dec; 35(12):12245-53. PubMed ID: 25195131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Diagnostic Power of Circulating miR-1246 in Screening Cancer: An Updated Meta-analysis.
    Huynh KQ; Le AT; Phan TT; Ho TT; Pho SP; Nguyen HT; Le BT; Nguyen TT; Nguyen ST
    Oxid Med Cell Longev; 2023; 2023():8379231. PubMed ID: 37122536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic and prognostic value of circulating miR-21 for cancer: a systematic review and meta-analysis.
    Wang Y; Gao X; Wei F; Zhang X; Yu J; Zhao H; Sun Q; Yan F; Yan C; Li H; Ren X
    Gene; 2014 Jan; 533(1):389-97. PubMed ID: 24076132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic value of circulating miRNA-122 for hepatitis B virus and/or hepatitis C virus-associated chronic viral hepatitis.
    Zhou X; Fang S; Wang M; Xiong A; Zheng C; Wang J; Yin C
    Biosci Rep; 2019 Sep; 39(9):. PubMed ID: 31427483
    [No Abstract]   [Full Text] [Related]  

  • 20. Circulating microRNAs as novel biomarkers in the diagnosis of prostate cancer: a systematic review and meta-analysis.
    Yin C; Fang C; Weng H; Yuan C; Wang F
    Int Urol Nephrol; 2016 Jul; 48(7):1087-95. PubMed ID: 27068818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.